Clinical trial
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
NCT00096616 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00096616 |
|---|---|
| Title | Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma |
| Official title | A Single Dose, Randomized, Double-blind Crossover Comparison of Combivent CFC MDI and Albuterol HFA MDI in Patients With Moderate to Severe Persistent Asthma and Persistent Symptoms Despite Treatment With Inhaled Corticosteroids |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Combivent® CFC MDI, Albuterol HFA MDI |
| Enrollment | 113 |
| Start date | Nov 1, 2004 |
| Primary completion | Mar 1, 2006 |
| First posted | Nov 15, 2004 |
| Last update posted | Nov 1, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: